General Info
Uri Lopatin is the CEO and Founder at Pardes Biosciences. Uri Lopatin attended National Institutes of Health.
Location: San Francisco
Country:
Industries:
Investment Regions:
Investment Stages: late-stage, pre-seed, seed, series-a
angel-individual
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: I found multiple sources showing Uri Lopatin as founder and CEO of Pardes Biosciences and that Pardes raised funding and went public via SPAC with investors (e.g., Foresite Capital, Gilead collaboration) in 2021 and subsequent corporate events. The most recent identifiable investment-related corporate event tied to Pardes Biosciences was post-IPO and acquisition activity through 2023 (e.g., Carver Biosciences appointment Jan 17, 2023 mentions Uri Lopatin). The last clear investment-related event linked to Uri Lopatin/Pardes is in 2023, which is between 12 and 6 months before the reference date, so classify as active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Uri Lopatin
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI